about
Recent Advances on Pathophysiology, Diagnostic and Therapeutic Insights in Cardiac Dysfunction Induced by Antineoplastic DrugsExercise Recommendations for the Management of Symptoms Clusters Resulting From Cancer and Cancer TreatmentsThe Role of Supportive Therapy in the Era of Modern Adjuvant Treatment - Current and Future Tools.Capecitabine (oral 5-fluorouracil pro-drug) treatment for colorectal carcinoma causing ischaemic chest painMetabolic syndrome and cardiovascular risk among long-term survivors of acute lymphoblastic leukaemia - From the St. Jude Lifetime Cohort.Career readiness in adult survivors of childhood cancer: a report from the St. Jude Lifetime Cohort StudyThe G671V variant of MRP1/ABCC1 links doxorubicin-induced acute cardiac toxicity to disposition of the glutathione conjugate of 4-hydroxy-2-trans-nonenalDetection of dose response in chronic doxorubicin-mediated cell death with cardiac technetium 99m annexin V single-photon emission computed tomographyPregnancy-associated cardiomyopathy in survivors of childhood cancerAdjuvant chemotherapy following complete resection of soft tissue sarcoma in adults: a clinical practice guidelineExercise Recommendations for Cancer-Related Fatigue, Cognitive Impairment, Sleep problems, Depression, Pain, Anxiety, and Physical Dysfunction: A Review.Deficits in physical function among young childhood cancer survivors.Targeted Agents for HER2-Positive Breast Cancer: Optimal Use in Older PatientsCardiovascular outcomes in women with advanced breast cancer exposed to chemotherapy.Evaluation of early subclinical cardiotoxicity of chemotherapy in breast cancerNutrition Modulation of Cardiotoxicity and Anticancer Efficacy Related to Doxorubicin Chemotherapy by Glutamine and ω-3 Polyunsaturated Fatty Acids.Cardiotoxic Effects of Short-Term Doxorubicin Administration: Involvement of Connexin 43 in Calcium Impairment.
P2860
Q28087776-1557EF3A-CFDB-4CA6-B5BB-4D6393DE0A3DQ33907387-1ED67EA5-1628-4D04-B46D-6F5257A109D1Q34095827-FE22D1FC-9ADD-41A0-BA21-323DF0328D86Q34527637-1E5FF800-C3F2-43CC-B739-4CAE2E9E19B9Q34742645-E58AF486-C6DC-40ED-A1FC-A6D37B1FFDA2Q35002237-E20A521F-3FD7-42BE-B2BC-5303E6F8B072Q35840905-5C8E5786-D6B4-4E29-80EA-C409C508F288Q36210537-5C115FAE-3DEF-45BF-B39A-05ACA535E3F1Q36348929-F0752FA1-E4C2-4699-A283-F391080BDCCEQ36674152-198EA6D9-B075-4B9D-817A-1FAFFFFCA120Q36825401-2BCE6F43-69F7-422E-A14F-604E200CF15AQ37033946-B58D7DD8-07FF-459B-A70A-14C371516EAEQ37191051-5E6FAB51-3988-4AF9-8FC5-D15DE5D2E7E9Q37202862-C5F3A81E-F144-4F52-B78B-2E7C8BC05A7FQ37680490-C83E177E-2322-444C-929A-54AE15B0CC88Q41048612-CFF03E1B-8E16-43BE-A1E9-FD7E6F5B6283Q46206820-0D27B48A-1E21-4946-A658-82126271B590
P2860
description
1992 nî lūn-bûn
@nan
1992 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
The cardiotoxicity of chemotherapeutic drugs.
@ast
The cardiotoxicity of chemotherapeutic drugs.
@en
type
label
The cardiotoxicity of chemotherapeutic drugs.
@ast
The cardiotoxicity of chemotherapeutic drugs.
@en
prefLabel
The cardiotoxicity of chemotherapeutic drugs.
@ast
The cardiotoxicity of chemotherapeutic drugs.
@en
P1433
P1476
The cardiotoxicity of chemotherapeutic drugs
@en
P2093
P304
P577
1992-10-01T00:00:00Z